• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    508.51 Down 10.27(1.98%) 4:00PM EDT
    |After Hours : 508.51 0.00 (0.00%) 4:34PM EDT
    Add to Portfolio
    Prev Close:518.78
    Open:523.45
    Bid:506.49 x 100
    Ask:514.00 x 100
    1y Target Est:617.48
    Beta:1.13191
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:506.83 - 523.64
    52wk Range:320.06 - 605.93
    Volume:606,573
    Avg Vol (3m):758,667
    Market Cap:53.73B
    P/E (ttm):128.28
    EPS (ttm):3.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Comparison

    Symbol% ChgMkt Cap
    REGNDown 1.98%53.73B
    AMGNDown 2.01%113.15B

    Key Statistics

    Forward P/E (1 yr):34.22
    P/S (ttm):15.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :12.23
    Quarterly EPS Est (Sep-15) :3.13
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.86

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback